Canada markets close in 2 hours 8 minutes

Amylyx Pharmaceuticals, Inc. (AMLX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
1.9550-0.0350 (-1.76%)
As of 01:51PM EDT. Market open.
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
345
380,786
22,230
0
0
Cost of Revenue
25,441
25,441
2,993
0
-
Gross Profit
355,345
355,345
19,237
0
-
Operating Expenses
Research Development
84,031
128,187
93,450
44,040
24,594
Selling General and Administrative
101,205
188,356
127,128
38,933
15,061
Total Operating Expenses
185,236
316,543
220,578
82,688
39,005
Operating Income or Loss
-185,063
38,802
-201,341
-82,688
-39,005
Interest Expense
-
-
-
0
2,288
Total Other Income/Expenses Net
79
-660
-551
-5,279
-1,001
Income Before Tax
-183,820
54,297
-197,601
-87,931
-42,280
Income Tax Expense
5,026
5,026
774
0
-
Income from Continuing Operations
-184,015
49,271
-198,375
-87,931
-42,280
Net Income
-184,015
49,271
-198,375
-87,931
-42,280
Net Income available to common shareholders
-184,015
49,271
-198,375
-87,931
-42,280
Basic EPS
0.04
0.73
-3.39
-1.59
-0.92
Diluted EPS
0.01
0.70
-3.39
-1.59
-0.92
Basic Average Shares
66,716
67,234
58,496
55,216
45,951
Diluted Average Shares
68,981
69,991
58,496
55,216
45,951